Disease-relevant autoantibodies in first episode schizophrenia.

Disease-relevant autoantibodies in first episode schizophrenia.

Opis bibliograficzny
Główni autorzy:	Zandi, MS, Irani, SR, Lang, B, Waters, P, Jones, P, McKenna, P, Coles, A, Vincent, A, Lennox, B
Format:	Journal article
Język:	English
Wydane:	2011

Podobne zapisy

ANTI-GAD65, NMDAR AND VGKC ANTIBODIES DETECTED IN FIRST EPISODE PSYCHOSIS
od: Lennox, B, i wsp.
Wydane: (2009)

Screening for encephalitis-causing autoantibodies in serum and CSF of first-episode psychosis patients and controls
od: Theorell, J, i wsp.
Wydane: (2020)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
od: Theorell, J, i wsp.
Wydane: (2021)

Autoantibodies associated with diseases of the CNS: new developments and future challenges.
od: Vincent, A, i wsp.
Wydane: (2011)

Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults.
od: Vincent, A, i wsp.
Wydane: (2011)

Decision making deficits in patients with first-episode and chronic schizophrenia.
od: Hutton, S, i wsp.
Wydane: (2002)

The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins.
od: Vincent, A, i wsp.
Wydane: (2010)

Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.
od: Irani, SR, i wsp.
Wydane: (2014)

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
od: Michael, S, i wsp.
Wydane: (2020)

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
od: Pollak, T, i wsp.
Wydane: (2018)

Encephalitis and schizophrenia: a matter of words reply
od: Lennox, B, i wsp.
Wydane: (2012)

Absence of neuronal autoantibodies in neuropsychiatric systemic lupus erythematosus
od: Varley, JA, i wsp.
Wydane: (2020)

Antibody-mediated encephalitis: a treatable cause of schizophrenia.
od: Lennox, B, i wsp.
Wydane: (2012)

Linear- versus conformational-protein directed autoantibodies in neuropsychiatric systemic lupus erythematosis
od: Varley, J, i wsp.
Wydane: (2017)

CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
od: Michael, S, i wsp.
Wydane: (2019)

Autoantibody testing in encephalopathies.
od: Lee, R, i wsp.
Wydane: (2012)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
od: Jakob Theorell, i wsp.
Wydane: (2021-11-01)

CXCL13 levels and autoantibody epitope specificities in LGI1-autoantibody syndromes
od: Michael, S, i wsp.
Wydane: (2019)

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
od: Thomas A. Pollak, i wsp.
Wydane: (2018-07-01)

Republished review: Autoantibody testing in encephalopathies.
od: Lee, R, i wsp.
Wydane: (2012)

Autoantibody-mediated disorders of the central nervous system.
od: Irani, S, i wsp.
Wydane: (2008)

The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis
od: Ramanathan, S, i wsp.
Wydane: (2019)

Autoantibodies in epilepsy
od: Lang, B, i wsp.
Wydane: (2007)

Autoantibody-mediated neurological diseases
od: Varley, JA, i wsp.
Wydane: (2020)

Diagnostic use of autoantibodies in myasthenia gravis.
od: Leite, M, i wsp.
Wydane: (2010)

Pathogenicity of autoantibodies in stiff-person syndrome
od: Chang, T, i wsp.
Wydane: (2008)

The experience of using aripiprazole in a serivice for first episode psychoisis
od: Shoesmith, W, i wsp.
Wydane: (2006)

MORVAN'S SYNDROME: CLINICAL AND SEROLOGICAL FINDINGS IN 27 CASES
od: Irani, SR, i wsp.
Wydane: (2011)

First episode schizophrenia
od: Nadira Khamker
Wydane: (2015-09-01)

The immunology underlying CNS autoantibody diseases
od: Cleaver, J, i wsp.
Wydane: (2024)

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.
od: Brenner, T, i wsp.
Wydane: (2013)

Real-world prevalence of autoantibodies in epilepsy
od: McGinty, RN, i wsp.
Wydane: (2020)

Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.
od: Varley, J, i wsp.
Wydane: (2014)

Controversies in the detection of neural autoantibodies
od: Philippa Pettingill, i wsp.
Wydane: (2016-09-01)

A novel antigenic target in Morvan's syndrome
od: Irani, SR, i wsp.
Wydane: (2008)

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
od: McGinty, R, i wsp.
Wydane: (2020)

Autoantibodies to ion channels at the neuromuscular junction.
od: Lang, B, i wsp.
Wydane: (2003)

The functional anatomy of auditory hallucinations in schizophrenia.
od: Lennox, B, i wsp.
Wydane: (2000)

Autoantibodies and the nervous system
od: Vincent, A, i wsp.
Wydane: (2008)

Serum Autoantibodies: From Identification to Clinical Relevance
od: Pietro Invernizzi, i wsp.
Wydane: (2013-01-01)